Search
Patexia Community

Innovation, Technology, and IP News

Patexia Insight 194: The Top Lateral Moves of PTAB Attorneys in 2023

The Patent Trial and Appeal Board (PTAB) holds a pivotal position within intellectual property law, wielding substantial influence over patent validity determinations and dispute...

The First FDA Approved, Chinese Developed, PD-1 Inhibitor For Nasopharyngeal Carcinoma

Written by: Jason J. Jardine On October 27th, 2023, the U.S. Food and Drug Administration (FDA) approved LOQTORZITM (toripalimab-tpzi), developed by Coherus BioSciences, Inc...

Tata Faces Trade Secrets Setback: $210M Damages in DXC Technology Case, Jury Says

Tata Consultancy Services (TCS), a prominent Indian software conglomerate, has recently been embroiled in a legal battle with DXC Technology, resulting in a substantial setback. A ...

FDA Issues Long-Overdue Regulations on Direct-To-Consumer Advertisements for Prescription Medications

  Written by: Lucas P. Koziol, Ph.D. & Michael L. Fuller On November 21, 2023, the FDA published its final rule changing how prescriptions medicines are advertised to...

Feed tagged as "cafc":
The legal battle between chipmaker Intel Corporation and patent holding company VLSI has taken another turn as the US Court of Appeals for ... Read More »
Tomorrow marks the release of our third annual CAFC Intelligence 2023 Report. This comprehensive report delves into the wealth of statistics and... Read More »
Patent litigation is a complex legal process that often involves disputes over intellectual property rights, particularly the validity and ... Read More »
The United States Court of Appeals for the Federal Circuit (CAFC) has been at the forefront of shaping patent law in the United States... Read More »
In the ever-evolving landscape of patent law, the Court of Appeals for the Federal Circuit (CAFC) has played a pivotal role in shaping the ... Read More »
The Supreme Court is the highest court in the United States, and its decisions have a significant impact on the country's legal... Read More »
In late October, we published our CAFC Intelligence report, the second annual report covering the patent-related CAFC appeals originating from... Read More »
In late October, we released our second annual CAFC Intelligence Report. The report provided high-level statistics and insights and evaluated the... Read More »
There had been only two cases where damages over $2 billion have been awarded in a patent litigation case, in Pfizer vs Teva... Read More »
  In 2019, Stephen Thaler filed two patent applications, 16/524,350 (teaching a “Neural Flame”) and 16/524,532... Read More »
Tomorrow we will release our 2022 CAFC Intelligence Report, where we have analyzed all the patent-related CAFC appeals from the USPTO, ITC, or... Read More »
This month we will publish our second annual CAFC Intelligence Report 2022, which covers the Court of Appeals for the Federal Circuit (CAFC). This... Read More »
The verdict was affirmed just last month but the history of this case goes back to 2009. Orange Bang sued Vital Pharmaceuticals because... Read More »
We have analyzed all the patent-related CAFC appeals, originating from the PTAB, ITC or district courts. The analysis covers a 5-year period, from January 1, 2016... Read More »
Just last Friday, June 11, the U.S District Court for the Northern District of California’s grant of a motion to dismiss for Apple and Samsung in a patent... Read More »
PTAB Appeals Focused on Merits The SCOTUS re-calibrated the PTAB’s appeal bar in Thryv, Inc v. Click-To-Call Techs., LP., explaining that potential... Read More »
Are Biosimilar Development Efforts Enough? In Momenta Pharmaceuticals, Inc. v. Bristol-Myers Squibb Co. (here), the Federal Circuit was poised to explore the... Read More »
Change in Claim Construction Standard Provides Greater Appellate Opportunity Some months back the Patent Trial & Appeal Board (PTAB) proposed dropping the... Read More »
On September 20, 2016, the U.S. Court of Appeals for the Federal Circuit issued an opinion affirming the summary judgement that Abbott’s U.S. Patent No... Read More »
The Federal Circuit recently decided two related cases concerning media content delivery patents1 owned by Affinity Labs of Texas, LLC.  In both cases, the... Read More »
Show more Newsfeed posts
Menu